Panavance Therapeutics
  • Our Science
    • Pipeline
    • About Misetionamide
    • Mechanism of Action
  • About
    • About Persevere
    • Leadership
    • Advisors
    • Contact Persevere
  • Resources
    • Publications
    • Press Releases

Let’s engage.

In Vitro Experiments on the Effects of GP-2250 on BRAF-Mutated Melanoma Cell Lines and Benign Melanocytes

November 8, 2023 / 0 Minute Read

persevere therapeutics

  • Our Science
  • About
  • Resources
  • LinkedIn

+1.610.922.1910

Copyright © 2026 Persevere Therapeutics Inc.